Genetic Etiology of Miscarriage in a Vietnamese Cohort Using CNV-Seq and Exome Sequencing
Key finding:
Pregnancy loss affects approximately 15% of pregnancies worldwide, with genetic abnormalities being a major cause. This study aimed to investigate the genetic etiologies of pregnancy loss in Vietnam and to characterize associated clinical features.Publisher:Prenatal Diagnosis
Publication date:12 July 2026This publication supports for the following genetic testing:
Gene Solutions Advances Precision Oncology Education in Malaysia with the ”Beyond Actionable” Academy
Key finding:
KUALA LUMPUR, Malaysia, Aug. 4, 2026 /PRNewswire/ — Gene Solutions Malaysia hosted the Precision Oncology Academy 2026 on 25 July 2026 at the Sheraton Petaling Jaya Hotel under the theme ”Beyond Actionable”. An extension of the international K-CONNECT Platform and the recent K-CONNECT Summit 2026 in Vietnam, the Academy brought together oncology experts from the United Arab Emirates, Singapore, Malaysia, US and Vietnam. Through scientific lectures, multidisciplinary case discussions and interactive workshops, the programme addressed a central question: How can a deeper understanding of each patient’s cancer lead to more informed treatment decisions?Authors:
GENE SOLUTIONS SGP PTE. LTD.Publisher:PR Newswire
Publication date:04 August 2026
Gene Solutions Showcases Global Evidence and Responsible Innovation in Prenatal and Women’s Genomic Health at ISPD 2026
Key finding:
SINGAPORE, July 22, 2026 /PRNewswire/ — Gene Solutions, a global biotechnology company focused on accessible and responsible genomics, participated as a Premier Partner at the 30th International Conference on Prenatal Diagnosis and Therapy (ISPD 2026), held virtually from July 7–9. Across an industry symposium, a scientific session, two oral presentations and three scientific posters, the company presented data and expert perspectives on how genomics, epigenomics and artificial intelligence may support more comprehensive, personalized and minimally invasive care throughout pregnancy and across women’s health.Authors:
GENE SOLUTIONS SGP PTE. LTD.Publisher:PR Newswire
Publication date:22 July 2026
Gene Solutions’ SPOT-MAS 10 Places Asia-Led Cancer Screening Innovation in the Global Spotlight
Key finding:
A blood-based cancer screening technology developed in Asia is gaining international attention after real-world data from more than 84,145 individuals were presented at ASCO Breakthrough 2026 and highlighted by the American Society of Clinical Oncology. For Gene Solutions, this milestone underscores the growing global relevance of Asia-led multi-cancer detection innovation.Authors:
GENE SOLUTIONS SGP PTE. LTD.Publisher:PR Newswire
Publication date:07 July 2026This publication supports for the following genetic testing:
Gene Solutions Hosts K-CONNECT Summit 2026, Uniting Oncology Experts Across Asia-Pacific
Key finding:
DA NANG, Vietnam, June 18, 2026 /PRNewswire/ — Gene Solutions announced the successful conclusion of K-CONNECT Summit 2026, a regional scientific forum that brought together leading oncology experts, clinicians, researchers and healthcare stakeholders to discuss how Artificial Intelligence (AI) and multi-omics are reshaping cancer care across Asia-Pacific.Authors:
GENE SOLUTIONS SGP PTE. LTD.Publisher:PR Newswire
Publication date:18 June 2026
K-ACCELERATE: A Multicenter Prospective Trial Evaluating the Utility of a ctDNA-Based Assay for Accelerating Multi-Cancer Diagnosis in High-Risk Symptomatic Participants
Authors:
Phuong Thuy Le1, Van Thien Chi Nguyen1, Thi Hue Hanh Nguyen1, Dac Ho Vo1 , Luu Hong Dang Nguyen1, Ngoc Minh Phan1, Viet Trinh Ngo1, Thi Ngoc Tien Nguyen1, Thi Van Phan1, Duy Sinh Nguyen1, Hung Sang Tang1, Hoa Giang1, Minh Duy Phan1, Hoai-Nghia Nguyen1, Le Son Tran1*Publisher:ASCO Annual Meeting
Publication date:01 June 2026This publication supports for the following genetic testing:
Leveraging a hybrid tumor-informed and tumor-agnostic ctDNA assay for optimal ctDNA-MRD detection: A real-world study in Southeast Asia
Authors:
Van-Anh Nguyen Hoang, Tu Nguyen, Le-Tho T Vo, Lan N TuPublisher:ASCO Annual Meeting
Publication date:30 May 2026
PROSPECTIVE VALIDATION OF A COST-EFFECTIVE MULTIMODAL CELL-FREE DNA ASSAY FOR EARLY LUNG CANCER DETECTION IN SYMPTOMATIC AND HIGH-RISK COHORTS: AN INTERIM REPORT
Authors:
Van Thien Chi Nguyen, Dac Ho Vo, Trung Hieu Tran, Ngoc Tan Pham, Trong Hieu Nguyen, Thi Van Phan, Thi Ngoc Tien Nguyen, Hoang Anh Cao, Luu Hong Dang Nguyen, Duy Sinh Nguyen, Hung Sang Tang, Hoa Giang, Minh Duy Phan, Hoai-Nghia Nguyen, Le Son Tran1Publisher:International Association for the Study of Lung Cancer (ACLC)
Publication date:20 October 2025This publication supports for the following genetic testing:
CLINICAL UTILITY OF A MULTI-OMIC, cfDNA-BASED ASSAY IN THE EARLY DETECTION OF LUNG CANCER: A CASE SERIES
Authors:
Hong-Dang Luu Nguyen, Phuong-Thuy Le, Minh-Anh Thi Nguyen, Ngoc-Minh Phan, Khanh-Nhu Huynh, Viet-Trinh Ngo, Le-Son Tran, Hung- Sang Tang, Duy-Sinh NguyenPublisher:International Association for the Study of Lung Cancer (ACLC)
Publication date:20 October 2025This publication supports for the following genetic testing:
A Novel Cell-Free Multi-Omics Approach For Enhancing Multi-Cancer Early Detection
Authors:
Thien-Chi Van Van Nguyen¹˒², Anh-Nhu Nguyen¹˒², Thien-Phuc Hoang Nguyen¹˒², Hanh Thi-Hue Nguyen¹˒², Trung-Hieu Tran¹˒², Tien-Anh Nguyen¹˒², Trang Thi Tran¹˒², Trong Hieu Nguyen¹˒², Hoa Giang¹˒², Minh-Duy Phan¹˒², Hoai-Nghia Nguyen¹˒², Le Son Tran¹˒²Publisher:ASCO Breakthrough
Publication date:09 August 2024This publication supports for the following genetic testing:
Tissue of origin detection for cancer tumor using low-depth cfDNA samples through combination of tumor-specific methylation atlas and genome-wide methylation density in graph convolutional neural networks
Authors:
Nhu Nhat Tan Doan¹#*, Trong Hieu Nguyen¹#*, Trung Hieu Tran¹, Le Anh Khoa Huynh¹˒², Phuoc Loc Doan¹, Thi Hue Hanh Nguyen¹, Van Thien Chi Nguyen¹, Giang Thi Huong Nguyen¹, Hoai-Nghia Nguyen¹, Hoa Giang¹, Le Son Tran¹, Minh Duy Phan¹*Publisher:ASCO Breakthrough
Publication date:09 August 2024
Multimodal analysis of methylation and fragmentomic profiles in plasma cell free DNA for differentiation of benign and malignant breast tumors
Authors:
Thi Tuong Vi Van¹*, Hanh Thi-Hue Nguyen¹, Thien-Chi Van Van Nguyen¹, Dac Ho Vo¹, Trung Hieu Tran², Trong Hieu Nguyen², Nhu Nhat Tan Doan², Le Anh Khoa Huynh², Xuan Vinh Nguyen², Hoa Giang¹˒², Minh-Duy Phan¹˒², Hoai Nghia Nguyen², Le Son Tran¹˒²*Publisher:ASCO Breakthrough
Publication date:09 August 2024This publication supports for the following genetic testing:
1
2
3
4
5
…
9
